본문 바로가기
KERD
논문KCI 등재

Reply to Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

참고문헌 (11)

  1. Rujittika Mungmunpuntipantip, "Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”", Clinical and Molecular Hepatology, 29(1), pp.168~168 (2023), 대한간학회
  2. Ka Shing Cheung, "COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis", Clinical and Molecular Hepatology, 28(4), pp.890~911 (2022), 대한간학회
  3. Ju-Yeon Cho, "Forms of cholangitis to be considered after SARS-CoV-2 infection", Clinical and Molecular Hepatology, 28(4), pp.929~930 (2022), 대한간학회
  4. Soon Kyu Lee, "Autoimmune liver disease represented as primary biliary cholangitis after SARS-CoV-2 infection: A need for population-based cohort study", Clinical and Molecular Hepatology, 28(4), pp.926~928 (2022), 대한간학회
  5. Ka Shing Cheung, "Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipients", Clinical and Molecular Hepatology, 28(3), pp.553~564 (2022), 대한간학회[DOI]
  6. Cheung KS, "Association between recent usage of antibiotics and immunogenicity within six months after COVID-19 vaccination", Vaccines(Basel), 10, pp.1122~ (2022)
  7. Cheung KS, "Association between angiotensin blockade and COVID-19 severity in Hong Kong", CMAJ, 192, pp.E635~ (2020)
  8. Cheung KS, "Association between famotidine use and COVID-19 severity in Hong Kong : a territory-wide study", Gastroenterology, 160, pp.1898~1899 (2021)
  9. Timmermann L, "Humoral immune response following SARSCoV-2 vaccination in liver transplant recipients", Vaccines(Basel), 9, pp.1422~ (2021)
  10. Ma Q, "Global percentage of asymptomatic SARS-CoV-2 infections among the tested population and individuals with confirmed COVID-19 diagnosis : a systematic review and meta-analysis", JAMA Netw Open, 4, pp.e2137257~ (2021)
  11. Ju-Yeon Cho, "Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline", Clinical and Molecular Hepatology, 27(4), pp.515~523 (2021), 대한간학회[DOI]

관련 논문AI추천

Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”Rujittika Mungmunpuntipantip, Viroj Wiwanitkit대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제1호COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysisChiu Hang Mok, Ivan FN Hung, Ka Shing Cheung, Man Fung Yuen, Ruiqi Zhang, Wai Kay Seto, Xianhua Mao대한간학회 · Clinical and Molecular Hepatology2022 · 제28권 제4호Reply to Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”Hyung Joon Yim, Tae Hyung Kim, Young Kul Jung대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제1호Correspondence on Editorial regarding “Baveno- VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”Giulia Tosetti, Massimo Primignani, Sanchit Sharma, Xiaolong Qi, Yu Jun Wong대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제1호Correspondence on Letter regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”Ju Dong Yang, Yee Hui Yeo대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제1호Correspondence on Letter 1 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”Jamil S. Samaan, Wee Han Ng, Yee Hui Yeo대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제3호

이 간행물의 다른 논문 (46건)